Advertisement

Clinical Trials

  • Kim F. Rhoads
  • Julio E. Garcia-Aguilar
Chapter

Background

Total mesorectal excision (TME) is accepted today as the standard surgical therapy for rectal cancer. Tumors located in the middle or upper third of the rectum can be removed with a restorative anterior resection or low anterior resection (LAR), while those in the lower third have been historically treated with abdominoperineal resection. These aggressive surgical approaches adhere to the successful paradigm of wide resection with a diagnostic and possibly therapeutic lymphadenectomy. Owing to the radical nature of these operations, however, they can and do result in significant mortality, morbidity [1, 2, 3] and functional disturbances [4, 5].

Local excision, whether performed by the conventional transanal approach or by transanal endoscopic microsurgery (TEM), is a less invasive alternative approach to the treatment of early rectal cancer. While local excision can be potentially curative for tumors limited to the rectal wall, recent series have reported high rates of local...

Keywords

Rectal Cancer Local Excision Transanal Endoscopic Microsurgery Chemoradiation Therapy Early Rectal Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rothenberger DA, Wong WD. Abdominoperineal resection for adenocarcinoma of the low rectum. World J Surg, 1992. 16 (3): 478–85CrossRefPubMedGoogle Scholar
  2. 2.
    Hughes ES, McDermott FT, Masterton JP, Polglase AL. Operative mortality following excision of the rectum. Br J Surg, 1980. 67 (1): 49–51CrossRefPubMedGoogle Scholar
  3. 3.
    Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg, 1983. 70 (8): 460–2CrossRefPubMedGoogle Scholar
  4. 4.
    Karanjia ND, Schache DJ, Heald RJ. Function of the distal rectum after low anterior resection for carcinoma. Br J Surg, 1992. 79 (2): 114–6CrossRefPubMedGoogle Scholar
  5. 5.
    Lee SJ, Park YS. Serial evaluation of anorectal function following low anterior resection of the rectum. Int J Colorectal Dis, 1998. 13 (5): 241CrossRefPubMedGoogle Scholar
  6. 6.
    Bentrem DJ, Okabe S, Wong WD, Paty PB. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg, 2005. 242 (4): 472–7PubMedGoogle Scholar
  7. 7.
    Endreseth BH. Transanal excision versus major surgery for T1 rectal cancer. Dis Colon Rectum, 2005. 48 (7): 1380–8CrossRefPubMedGoogle Scholar
  8. 8.
    Mellgren, A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum, 2000. 43 (8): 1064–71CrossRefPubMedGoogle Scholar
  9. 9.
    Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum, 2004. 47 (11): 1773–9CrossRefPubMedGoogle Scholar
  10. 10.
    Buess G, Theiss R, Pichlmaier H. [Transanal Endoscopic Microsurgery] Leber Magen Darm, 1985. 15 (6): 271–9PubMedGoogle Scholar
  11. 11.
    Burghardt J, Buess G. Transanal endoscopic microsurgery (TEM): a new technique and development during a time period of 20 years. Surg Technol Int, 2005:14:131–7PubMedGoogle Scholar
  12. 12.
    Russell AH, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys, 2000. 46 (2):313–22CrossRefPubMedGoogle Scholar
  13. 13.
    NEW Steele GD, et al. Sphincter-sparing treatment for distal recual adenocarcinoma. Ann Surg Oncol, 1999. 6 (5): 433–41CrossRefPubMedGoogle Scholar
  14. 14.
    Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery versus anterior resection. Dis Colon Rectum, 1996. 39 (9): 969–76CrossRefPubMedGoogle Scholar
  15. 15.
    Lezoche E, Guerrieri M, Paganini AM, De Sanctis A. Transanal endoscopic versus total mesorectal laparoscopic resections of T2N0 low rectal cancers after neoadjuvant treatment. Surg Endosc, 2005. 19: 751–6CrossRefPubMedGoogle Scholar
  16. 16.
    Lezoche E, Guerrieri M, De Sanctis A, Perretta S. Management of T2N0 rectal tumors: long-term randomized study comparing transanal endoscopic microsurgery versus laparoscopic resections. Last on line access 11/28/2006 http://www.ssat.com/cgi-bin/abstracts/06ddw/SSAT_DDW06_80.cgi
  17. 17.
    Cataldo PA, O’Brien S, Osler T. Transanal endoscopic microsurgery: a prospective evaluation of functional results. Dis Colon Rectum, 2005. 48 (7): 1366–71CrossRefPubMedGoogle Scholar
  18. 18.
    National Cancer Institute website. Last access 12/19/2006 http://www.cancer.gov/search/ViewClinicalTrials.aspx
  19. 19.
    National Institutes of Health website. Last access 11/29/2006 http://www.clinicaltrials.gov
  20. 20.
    Dana Farber Cancer Institute. Last access 12/19/2006 http://www.danafarber.org/can/clinical
  21. 21.
    Memorial-Sloan Kettering Cancer Center. Last access 12/19/2006 http://www.mskcc.org/mskcc/html/5707.cfm
  22. 22.
    MD Anderson Cancer Center. Last access 11/29/2006 http://www.mdanderson.org/patients_public/clinical_trials

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Kim F. Rhoads
    • 1
  • Julio E. Garcia-Aguilar
  1. 1.Mt. Zion Cancer CenterUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations